AstraZeneca Building New COVID-19 Vaccine Plant in Germany
AstraZeneca Building New COVID-19 Vaccine Plant in Germany
GALWAY, IRELAND--February 23, 2021--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--AstraZeneca is planning to build a new COVID-19 vaccine plant in Germany with IDT Biologika to boost vaccine output and overcome problems with initial European supplies.
Within this article: Details new plant plans, partners,
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Ghana Hosts Fill-and-Finish Plant for BioNTech's COVID-19 Vaccine
- Hydrogen Fuel Cell Vehicles Gain Ground in Europe
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
